Teaser text

The UNSW Medicine Biodefence Collaboration is between the Kirby Institute and the UNSW School of Public Health and Community Medicine; bringing together chief investigators in Epidemic Response and complementary capabilities in public health interventions and acute response to biological threats.

Body Text

Competitive advantage

  • Joint capabilities from three of the world’s leading universities; UNSW, Arizona State University and King College London
  • Cross-disciplinary approaches to threat detection


  • Enhanced biodefence

Successful applications

  • NHMRC Centre for Research Excellence, Integrated Systems for Epidemic Response (ISER)
  • Identifying risk factors of a human-to-human transmissible form of highly pathogenic avian influenza H5N1, UNSW PluS Alliance
  • AIAA pandemic risk assessment
  • Defence Science and Technology, Chimera evolution

Capabilities and facilities

  • UNSW School of Public Health and Community Medicine
  • the Kirby Institute
  • Global Security PLuS partners

Our partners

  • Emergent Biosolutions
  • 3M
  • Bavarian Nordic
  • Siga Technologies
  • Leidos
  • Sanofi
  • Seqirus